Condition
    Strong Evidence
    Effectiveness 3/5

    D-Chiro-Inositol for PCOS (Polycystic Ovary Syndrome)

    D-chiro-inositol improves some PCOS markers, but myo-inositol has better evidence and high DCI doses may harm egg quality.

    Overview

    D-chiro-inositol improves some PCOS markers, but myo-inositol has better evidence and high DCI doses may harm egg quality.

    Verdict

    Mixed evidence

    How It Works

    D-chiro-inositol mediates insulin-stimulated glycogen synthesis, while myo-inositol governs FSH signalling and glucose uptake in the ovary; the ovarian ratio of the two is disturbed in PCOS.

    Dosing & Protocol

    Typical dose

    Recommended dose
    2 g myo-inositol plus 50 mg D-chiro-inositol twice daily (40:1 ratio). D-chiro-inositol alone was studied at 600-1200 mg/day with mixed results.
    Expected timeframe
    8-12 weeks for insulin markers; 3-6 months for cycles and androgen symptoms

    Protocol

    dose
    2 g myo-inositol + 50 mg D-chiro-inositol twice daily (total 4 g myo + 100 mg DCI/day)
    form
    Powder dissolved in water, or capsules
    steps
    Get a proper PCOS diagnosis and baseline labs: testosterone, SHBG, LH/FSH, fasting insulin, HbA1c, plus a pelvic ultrasound as indicated,Use the 40:1 myo:D-chiro combination — this outperforms D-chiro-inositol alone in most trials,Take twice daily; if GI upset occurs, start with half a dose for a week and titrate up,Combine with the interventions that carry the strongest PCOS evidence: resistance training, protein-forward meals and modest weight loss if applicable,Reassess cycles, androgen symptoms and insulin markers at 3 and 6 months,Keep D-chiro-inositol at or below 1200 mg/day — more is not better
    timing
    Morning and evening, with or before meals
    duration
    3-6 months minimum

    Evidence

    What the studies say

    Early trials of DCI reported improved insulin sensitivity, ovulation and androgen levels in PCOS. Later work found that high-dose DCI reduces oocyte quality and blastocyst rates, prompting a shift toward the physiological 40:1 myo-to-DCI ratio.

    Experts' opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond

    Score: 5/10
    2015
    systematic_review

    Facchinetti F, Bizzarri M, Benvenga S +13 more

    The 40:1 myo-inositol to D-chiro-inositol ratio reflects physiological plasma proportions and is recommended for restoring ovulation and insulin sensitivity, with high-dose D-chiro-inositol potentially detrimental to oocyte quality.

    View source

    Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-Based PCOS Guidelines

    Score: 9/10
    2024
    systematic_review

    Fitz V, Graca S, Mahalingaiah S +5 more

    Inositol improved fasting insulin and HOMA-IR versus placebo, with low-certainty effects on ovulation, hirsutism and androgens.

    View source

    Update on the Combination of Myo-Inositol / D-Chiro-Inositol for the Treatment of Polycystic Ovary Syndrome

    Score: 5/10
    2024
    systematic_review

    Lete I, Martinez A, Lasaga I +2 more

    High-dose isolated D-chiro-inositol has been associated with reduced oocyte quality, the so-called D-chiro-inositol paradox.

    View source

    Ovulatory and Metabolic Effects of D-Chiro-Inositol in the Polycystic Ovary Syndrome

    Score: 6/10
    1999
    rct
    n=44

    Nestler JE, Jakubowicz DJ, Reamer P +2 more

    Nineteen of 22 women receiving D-chiro-inositol ovulated, as compared with 6 of 22 in the placebo group.

    View source

    Safety

    Caveats

    Mixed verdict specifically for D-chiro-inositol alone — the combination form carries the better evidence. The DCI paradox means high doses can impair ovarian function and egg quality. Inositol is not a substitute for metformin where that is prescribed. Restoring ovulation restores fertility, so use contraception if pregnancy is not wanted. Use in pregnancy only under medical supervision.

    Less likely to help if

    Lean PCOS without insulin resistance, and women whose symptoms are driven by adrenal androgens, thyroid disease or hyperprolactinaemia rather than insulin.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.